Views & Analysis Division on European HTA There have been aspirations for closer collaboration between European Union (EU) Member States (MS) on Health Technology Assessment (HTA) for at least two decades.
Views & Analysis Mind the (implementation) gap Examining the true impact of a positive health technology assessment (HTA).
News FDA experts lukewarm on AZ's anticoagulant antidote Andexxa AstraZeneca is facing some pushback as it tries to upgrade anticoagulant antidote drug Andexaa to full approval in the US
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends